Note Regarding Forward-Looking Statements



Certain information in this report contains "forward-looking statements" within
the meaning of Section 27A of the Securities Act of 1933, as amended, Section
21E of the Securities Exchange Act of 1934, as amended, and the Private
Securities Litigation Reform Act of 1995. These forward-looking statements
generally can be identified by use of phrases or terminology such as "intend,"
"anticipate," "expects" or other similar words or the negative of such
terminology. Similarly, descriptions of Medifast's objectives, strategies,
plans, goals or targets contained herein are also considered forward-looking
statements. These statements are based on the current expectations of the
management of Medifast and are subject to certain events, risks, uncertainties
and other factors. These risks and uncertainties include, but are not limited
to, those described in our 2020 Form 10-K, this Form 10-Q and those described
from time to time in our future reports filed with the SEC. Although Medifast
believes that the expectations, statements and assumptions reflected in these
forward-looking statements are reasonable, it cautions readers to always
consider all of the risk factors and any other cautionary statements carefully
in evaluating each forward-looking statement in this report. All of the
forward-looking statements contained herein speak only as of the date of this
report.


The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements and related notes appearing elsewhere herein.

Overview

Medifast is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers Lifelong Transformation, One Healthy Habit at a Time®. Reflecting the success of our holistic approach to health and wellness, we have consistently grown revenue over the past five years. Of equal importance, we expect our differentiated model to deliver long-term growth in the foreseeable future.

Medifast has created a new business model by combining the most powerful aspects
of direct selling, while eliminating those dimensions that have typically
challenged other companies. Medifast is often compared to diet and weight
loss-only companies or to multi-level marketing companies, but our model is
different. We employ a differentiated direct-to-consumer sales model in which
91.0% of our revenue comes from subscription-based meal-plan orders.

Our OPTAVIA brand offers a highly competitive and effective lifestyle solution
centered on developing new healthy habits through smaller, foundational changes
called micro-habits. The program is built around four key components:



? Independent OPTAVIA Coaches: Provide individualized support and guidance to

clients on the path to optimal health and wellbeing.

? OPTAVIA Community: A Community of like-hearted people providing each other with

real-time connection and support.

? The Habits of Health® Transformational System: A proprietary system which

offers easy steps to a sustainably healthy lifestyle.

? Products & Plans: Clinically proven plans and scientifically developed

products, called "Fuelings," backed by dietitians, scientists and physicians.




We help clients achieve their health goals through a network of more than 52,000
independent OPTAVIA Coaches, 90.0% of whom were clients first, and have impacted
2.0 million lives to date. OPTAVIA Coaches introduce clients to a set of healthy
habits, in most cases starting with the habit of healthy eating, and offer
exclusive OPTAVIA-branded nutritional products, or Fuelings. Fuelings are
nutrient-dense, portion-controlled, nutritionally interchangeable and simple to
use. They are formulated with high-quality ingredients and are fortified with
probiotic cultures, vitamins and minerals, as well as other nutrients essential
for good health. Our products support the process of integrating healthy habits
into our clients' day-to-day lives.

                                       14

Table of Contents


The OPTAVIA coaching model is client-centric and boasts an energized health and
wellness community. It promotes holistic health and wellness and positions
healthy weight as a catalyst to greater lifestyle changes. OPTAVIA Coaches
provide personalized support to clients and motivate them by sharing their
passion for healthy living and lifestyle transformation. We believe this
personal coaching is an essential factor in client success based on findings
from a clinical study published in Obesity Science and Practice in 2018, which
validated the OPTAVIA model when its meal plan was combined with education and
support consistent with that provided by OPTAVIA Coaches.



The entrepreneurial spirit of our OPTAVIA Coaches is another key to our success,
as they create a continuous cycle of growth, activating new clients, many of
whom go on to become OPTAVIA Coaches. We offer economic incentives designed to
support each OPTAVIA Coach's long-term success, which we believe plays an
important role in their financial wellness, providing the opportunity to improve
their finances while changing the health trajectory of families, communities and
generations.1



OPTAVIA Coaches are independent contractors, not employees, who support clients
and market our products and services primarily through word of mouth, email and
via social media channels such as Facebook, Instagram, Twitter and video
conferencing platforms. As entrepreneurs, OPTAVIA Coaches market our products to
friends, family and other acquaintances. OPTAVIA products are shipped directly
to OPTAVIA clients who are working with an OPTAVIA Coach. OPTAVIA Coaches do not
handle or deliver merchandise to clients. This arrangement frees our OPTAVIA
Coaches from having to manage inventory and allows them to maintain an
arms-length transactional relationship while focusing their attention on support
and encouragement.

We are one of the fastest growing health and wellness companies in the United
States, with a large and growing market opportunity. Our scalable coach-based
approach drives both client success and growth. We believe our continued
investment in fostering a robust community around our OPTAVIA brand and our
OPTAVIA Coaching Model will continue to drive a sustainable, repeatable business
rhythm focused on our mission of offering the world Lifelong Transformation, One
Healthy Habit at a Time.

Our operations are conducted through our wholly owned subsidiaries, Jason
Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties,
LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate
Events, Inc., OPTAVIA (Hong Kong) Limited, OPTAVIA (Singapore) PTE. LTD and
OPTAVIA Health Consultation (Shanghai) Co., Ltd.

As we previously disclosed, global expansion is an important component of our
long-term growth strategy. In July 2019, we commenced our international
operations, entering into the Asia Pacific markets of Hong Kong and Singapore.
Our decision to enter these markets was based on industry market research that
reflects a dynamic shift in how health care is being prioritized and consumed in
those countries. The Company outsources a distribution center in Hong Kong to
give the Company adequate product distribution capacity for the foreseeable

future in these markets.



COVID-19 Update



A novel strain of coronavirus ("COVID-19") surfaced in late 2019 and has spread
around the world, including to the United States. In March 2020, the World
Health Organization declared COVID-19 a worldwide pandemic. As of April 2021,
the virus continues to spread and has had a significant impact on worldwide
economic activity and on macroeconomic conditions.



In response to the pandemic, many governments implemented policies intended to stop or slow the further spread of the disease, such as social distancing guidelines, shelter-in-place orders and other measures in response to the COVID-19

1 OPTAVIA makes no guarantee of financial success. Success with OPTAVIA results from successful sales efforts, which require hard work, diligence, skill, persistence, competence, and leadership. Please see the OPTAVIA Income Disclosure Statement (http://bit.ly/idsOPTAVIA) for statistics on actual earnings of Coaches.



                                       15

  Table of Contents

pandemic. Nutritional supplements and health foods have been designated
critical/essential infrastructure in the U.S.  As a manufacturer and distributer
of these products our manufacturing and distribution facilities remain fully
operational to date and we have not experienced any meaningful disruption to our
worldwide supply chain.  The Company's priorities during the COVID-19 pandemic
continue to be protecting the health and safety of our employees and OPTAVIA
Coaches, and their families and we have undertaken numerous steps and instituted
additional precautions to protect their safety and well-being, including:



instituting enhanced safety protocols, limited visitation to our plant and

? distribution center and rolling out additional sick leave (crisis pay) for our

onsite essential employees;

successfully implementing a work-from-home plan for all non-essential employees

? to comply with guidelines from government and health officials and also

extended crisis pay;

? changing the July 2020 OPTAVIA convention from a live event to a virtual event;

prioritizing production to our highest volume products limiting our stock

? keeping unit ("SKU") assortment to ensure that we are able to meet anticipated

product demand across core items;

providing additional health and safety precautions in our headquarters,

? manufacturing and distribution centers, including use of personal protective

equipment and frequent hand sanitization; and

? process controls in relation to social distancing, visitors, travel and


   quarantine.




Vaccines are available in various countries and distribution of the vaccine also
varies by country and in the U.S. by state. The duration and severity of this
COVID-19 pandemic is uncertain, and the extent to which the pandemic ultimately
impacts the Company's business, financial condition, results of operations, cash
flows, and liquidity may differ from management's current estimates. Factors
that could cause actual results to differ from management's estimates include
inherent uncertainties regarding the duration and further spread of the
outbreak, its severity, government actions taken to contain the virus or treat
its impact, changes in consumer behavior resulting from the pandemic and how
quickly and to what extent normal economic and operating conditions can resume.
The senior management team meets regularly to review and assess the status of
the Company's operations and health and safety of its various constituencies,
and will continue to proactively respond to the situation and communicate with
our supply chain partners to identify and mitigate risk and to manage inventory
levels. The Company may take further actions that alter its business operations
as may be required by governmental authorities, or that are determined to be in
the best interests of employees, OPTAVIA Coaches and consumers.



These uncertainties make it challenging for our management to estimate our future business performance. However, we intend to continue to actively monitor the impact of COVID-19 and related developments on our business.

Critical Accounting Policies and Estimates

Our unaudited condensed consolidated financial statements are prepared in accordance with GAAP. Our significant accounting policies are described in Note 1 to the unaudited condensed consolidated financial statements included in this report. We consider all of our significant accounting policies and estimates to be critical.





The preparation of our financial statements requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities, the disclosure of contingent assets and liabilities at the date of
the financial statements, and the reported amounts of revenue and expenses
during the reporting period. Management develops, and changes periodically,
these estimates and assumptions based on historical experience and on various
other factors that are believed to be reasonable under the circumstances. Actual
results may differ from these estimates under different assumptions or
conditions.

                                       16

  Table of Contents

Overview of Results of Operations

Our product sales accounted for approximately 98.0% of our revenues for each of the three months ended March 31, 2021 and 2020.





The following tables reflect our income statements (in thousands,
except percentages):


                                                Three months ended March 31,
                                                  2021               2020          $ Change    % Change

Revenue                                      $       340,669    $       178,461   $  162,208      90.9%
Cost of sales                                         92,122             43,221     (48,901)   (113.1)%
Gross profit                                         248,547            

135,240 113,307 83.8%



Selling, general, and administrative                 195,748            111,707     (84,041)    (75.2)%

Income from operations                                52,799             23,533       29,266     124.4%

Other income
Interest income, net                                      23                110         (87)    (79.1)%
Other income (expense)                                    19               (19)           38   (200.0)%
                                                          42                

91 (49) (53.8)%



Income from operations before income taxes            52,841             

23,624 29,217 123.7%



Provision for income tax                              11,778              

5,147 (6,631) (128.8)%



Net income                                   $        41,063    $        18,477   $   22,586     122.2%

% of revenue
Gross profit                                           73.0%              75.8%
Selling, general, and administrative                   57.5%              

62.6%


Income from operations                                 15.5%              

13.2%


Income from operations before income taxes             15.5%              13.2%






Revenue:  Revenue increased $162.2 million, or 90.9%, to $340.7 million for the

three months ended March 31, 2021 from $178.5 million for the three months ended
March 31, 2020. The average revenue per active earning OPTAVIA Coach was $6,454
for the three months ended March 31, 2021 compared to $5,333 for the
three months ended March 31, 2020. Increase in the productivity per active
earning OPTAVIA Coach for the quarter was driven by an increase in both the
number of clients supported by each Coach as well as an increase in average
client spend. The year-over-year growth in revenue resulted from more clients
participating in our Optimal Weight 5 & 1  Plan®. OPTAVIA-branded products
represented 88.9% of consumable units sold for the three months ended March 31,
2021 compared to 79.0% for the corresponding period in 2020. Consistent with
business and brand strategy, the Company decided to sunset the Medifast-branded
product line by the end of the second quarter of 2021.

Costs of sales:  Cost of sales increased $48.9 million, or 113.1%, to $92.1
million for the three months ended March 31, 2021 from the corresponding period
in 2020. The increase in cost of sales was primarily driven by an increase in
OPTAVIA product sales, higher product costs and shipping costs, as well as
inventory write-offs related to the sunset of Medifast-branded product line.
Acceleration of demand in OPTAVIA-branded products led to the increase in the
Company's use of co-manufacturers and the increased need to provide expedited
shipments of our products to keep customer experience at acceptable levels in
advance of our fulfillment capacity being fully on-line, both of these items
increased costs.

                                       17

  Table of Contents

Gross profit:  For the three months ended March 31, 2021, gross profit increased
$113.3 million, or 83.8%, to $248.5 million from the corresponding period in
2020. As a percentage of revenue, gross profit decreased 280 basis points to
73.0% for 2021 from 75.8% for 2020. The decrease in gross profit as a percentage
of revenue was primarily driven by higher product costs and shipping costs, as
well as obsolescence costs associated with the sunset of Medifast-branded
product line.



Selling, general, and administrative:  Selling, general, and administrative
("SG&A") expenses were $195.7 million for the three months ended March 31, 2021,
an increase of $84.0 million, or 75.2%, as compared to $111.7 million from the
corresponding period in 2020. As a percentage of revenue, SG&A expenses were
57.5% as compared to 62.6% for the three months ended March 31, 2021 and 2020,
respectively. The $84.0 million increase in SG&A for the quarter was primarily
due to higher OPTAVIA commission expense, increased salaries and benefits
related expenses for employees and increased credit card fees resulting from
higher sales. SG&A expenses included research and development ("R&D") costs of
$1.0 million and $0.5 million for the three months ended March 31, 2021 and
2020, respectively.



OPTAVIA commission expense, which is a variable expense, increased $71.9
million, or 96.7%, to $146.2 million for the three months ended March 31, 2021
from $74.3 million for the corresponding period in 2020. The increase was
primarily the result of increased OPTAVIA product sales. As OPTAVIA revenue
increased as a portion of the Company's total sales mix, the commission rate as
a percentage of revenue increased 130 basis points to 42.9% for the first
quarter of 2021 compared to 41.6% for the corresponding quarter last year. This
trend is the result of the success we are experiencing with our growing OPTAVIA
Integrated Coach Model. The total number of active earning OPTAVIA Coaches for
the three months ended March 31, 2021 increased to 52,500 from 32,600 for the
corresponding period in 2020, an increase of 61.0%.



Income from operations:  For the three months ended March 31, 2021, income from
operations increased $29.3 million to $52.8 million from $23.5 million for the
corresponding period in 2020 primarily as a result of increased gross profit
partially offset by increased SG&A expenses. Income from operations as a
percentage of revenue was 15.5% and 13.2% for the three months ended March

31,
2021 and 2020, respectively.


Other income: For the three months ended March 31, 2021 and 2020, other income (including interest income) was $0.0 million and $0.1 million, respectively.


Income from operations before income taxes:  Income from operations before
income taxes was $52.8 million for the three months ended March 31, 2021 as
compared to $23.6 million for the three months ended March 31, 2020, an increase
of $29.2 million. Income from operations before income taxes as a percentage of
revenue increased to 15.5% for the three months ended March 31, 2021 from 13.2%
for the three months ended March 31, 2020.



Provision for income tax:  For the three months ended March 31, 2021, the
Company recorded $11.8 million in income tax expense, an effective tax rate of
22.3%, as compared to $5.1 million in income tax expense, an effective tax rate
of 21.8%, for the three months ended March 31, 2020. The slight increase in the
effective tax rate was primarily driven by an increase in the state income tax
rate and limitations on the deductibility of officer compensation offset by an
increase in the tax benefit of stock compensation.

Net income: Net income was $41.1 million and $18.5 million, or $3.46 and $1.56 per diluted share, for the three months ended March 31, 2021 and 2020, respectively. The period-over-period changes were driven by the factors described above.

Liquidity and Capital Resources


The Company had stockholders' equity of $174.9 million and working capital of
$137.0 million at March 31, 2021 as compared with $157.2 million and $123.0
million at December 31, 2020, respectively. The $17.7 million net increase in
stockholders' equity reflects $41.1 million in net income for the three months
ended March 31, 2021 offset by $7.5 million spent on repurchases of the
Company's common stock and $16.9 million for declared dividends paid to holders
of the Company's common stock as well as the other equity transactions described
in the "Condensed Consolidated Statements of Changes in Stockholders' Equity"
included in our condensed consolidated financial statements included in this
report. The Company declared a quarterly dividend of $1.42 per share on March
18, 2021, to stockholders of record as of March 30, 2021 that will be paid in
the second quarter of 2021. While we intend to continue the dividend program and
believe

                                       18

  Table of Contents

we will have sufficient liquidity to do so, we can provide no assurance that we
will be able to continue to declare and pay dividends. The Company's cash, cash
equivalents and investment securities increased from $174.5 million at
December 31, 2020 to $212.9 million at March 31, 2021.

Net cash provided by operating activities increased $38.6 million to $65.3
million for the three months ended March 31, 2021 from $26.7 million for the
three months ended March 31, 2020 as a result of a $22.6 million increase in net
income and $14.5 million increase in operating assets and liabilities.

Net cash used in investing activities was $0.9 million for the three months
ended March 31, 2021 as compared to net cash provided by investing activities of
$0.7 million for the three months ended March 31, 2020. This change resulted
from a $4.3 million increase in cash used in capital expenditures for the three
months ended March 31, 2021 from the corresponding period in 2020 partially
offset by a $2.7 million increase in sale and maturities of investment
securities.

Net cash used in financing activities increased $8.5 million to $22.2 million for the three months ended March 31, 2021 from $13.7 million for the three months ended March 31, 2020. This increase was due to a $7.5 million increase in stock repurchases and a $1.3 million increase in net shares repurchased for employee taxes.

In pursuing its business strategy, the Company may require additional cash for operating and investing activities. The Company expects future cash requirements, if any, to be funded from operating cash flow and financing activities.

The Company evaluates acquisitions from time to time.

© Edgar Online, source Glimpses